Dr. Reddys Laboratories Ltd.

Dr. Reddys Laboratories is currently trading at Rs. 4439.80, down by 58.85 points or 1.31% from its previous closing of Rs. 4498.65 on the BSE.

The scrip opened at Rs. 4511.15 and has touched a high and low of Rs. 4527.15 and Rs. 4436.35 respectively. So far 14198 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 5514.65 on 21-Sep-2020 and a 52 week low of Rs. 2497.60 on 19-Mar-2020.

Last one week high and low of the scrip stood at Rs. 4551.15 and Rs. 4417.95 respectively. The current market cap of the company is Rs. 73834.04 crore.

The promoters holding in the company stood at 26.73%, while Institutions and Non-Institutions held 43.86% and 29.41% respectively.

Dr. Reddy's Laboratories’ API manufacturing plant at New York has received three observations from United States Food and Drug Administration (USFDA). The audit of API manufacturing plant at Middleburg, New York has been completed by the USFDA. The company will address three observations comprehensively within the stipulated timeline. Currently, the company does not have any sales from this plant.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.